0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
Predicting Adverse Drug Reactions with Advanced Machine Learning Techniques
نویسندگان :
AlI Mohammadian
1
Sara Haghighi Bardine
2
Fatemezahra Alizade
3
1- Amol University of Special Modern Technologies
2- Amol University of Special Modern Technologies
3- Amol University of Special Modern Technologies
کلمات کلیدی :
Adverse drug reactions،Support Vector Machine،Gradient Boosted Trees،Ensemble leaning
چکیده :
Drug design is a complex and resource-intensive process, partly due to the challenge of predicting adverse drug reactions (ADRs), which can impact drug safety and efficacy and only becomes evident after clinical trials on a drug has already began. In this study, we developed machine learning (ML) methodologies aimed at predicting ADRs by leveraging data from the SIDER databases, which contain ADR information for approved drugs and clinical trials, respectively. ADR data was collected from 1,430 approved drugs. Molecular descriptors, such as polar surface area and molecular weight, were extracted from drug SMILES strings, and Extended Connectivity Fingerprints (ECFP) were used for molecular fingerprinting. We employed several machine learning algorithms, including Support Vector Machine (SVM), Random Forest (RF), and Gradient Boosted Trees (GBT), for ADR classification tasks. To ensure robust evaluation and optimization of these ML methods, we utilized metrics such as accuracy, precision, recall, and F1-score, while addressing class imbalance using SMOTE-NC. Our results demonstrated that no single algorithm outperformed others in all cases; for example, the best balance between precision and recall for predicting common ADRs might be different from those algorithms for rare ADRs, or some algorithms perform better for some tissues and worse for the others. We suggest the use of ensemble learning to combine the strengths of different algorithms for improved ADR prediction in drug discovery. Future work should focus on optimizing ensemble models and extending the approach to other drug classes
لیست مقالات
لیست مقالات بایگانی شده
A Computational Approach to Identify Potent Inhibitors of Janus Kinase 1 from Natural Products: Structure-Based High-Throughput Virtual Screening and LightGBM Classifier.
Parisa Valipour
Curcumin’s Journey Through Cellulose: Binding Dynamics Across Cellulose-derived Bio-Nanofibers
Ayla Esmaeilzadeh - Maryam Azimzadeh Irani - Mehdi Jahanfar - Naser Farrokhi
ATIC as a Theranostic Biomarker in Gastrointestinal Cancers: Insights from Autophagy Pathway Analysis
Pooya Jalali - Maryam Eghbali - Zahra Eghabli - Yasaman Gholinezhad - Zahra Salehi
Identification of circRNA-miRNA-mRNA Interaction in Myocardial Infarction
Amir Hesam Pahlevani - Ashkan Nazari - Kiarash Zare - Mohammad Ghorbani - Abdolhakim Aalkamel - Mohammad Mehdi Naghizadeh
Towards Efficient Recombinant Protein Production: In-silico screening of signal peptides for secretory production of recombinant factor C in mammalian cells
Maryam Latifi - Kosar Asadi - Mansoureh Shahbazi Dastjerdeh
Diagnosis of Diabetic Retinopathy with Fuzzy Technique and Deep Learning
Samaneh Noroozi - Sajad Haghzad Klidbary
Drug reproposing for brain cancer
Zahra Shahini - Farinaz Roshani
BIRC5: The Silent Architect of Tumor Persistence and Senescence in Hepatocellular Carcinoma
Amirhosein Farrokhzad - Maryam Kaboli - Elahe Hoseinnia - Elham Rismani - Massoud Vosough
Innovative Biomarkers for Lung Cancer Classification and Prediction Using High-Dimensional Machine Learning: A Novel Approach to Targeted Therapies
Marzie Shadpirouz - Morteza Hadizadeh - Zahra Salehi - Maziyar Veisi - Reza Maddah - Mohammad Shirinpour - Kazem Abbaszadeh-Goudarzi - Kaveh Kavousi
Exploring the Anticancer Potential of Flavonoids from Morus alba Against Breast Cancer: An In Silico Approach
Kimia Asadi - Negar Ghaleh Navi - Ehsan Karimi
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0